Endometrial Cancer Archives - Cancer Therapy Advisor

Black patients were half as likely to receive remdesivir as White patients, according to researchers from the CCC19.

TVUS ET Screening Misses More Cases of Endometrial Cancer in Black Women Than in White Women

By

July 30, 2021

The disparity is due to the greater prevalence of fibroids and nonendometrioid histologic type in Black women, according to researchers.

Some studies have shown that up to 40% of obese patients receive lower doses of chemotherapy.

ASCO 2021

Rising Incidence of Endometrial Cancer Linked to Obesity in Younger Women

By

Sucharita Mistry, PhD

June 21, 2021

Data showed increases in endometrial cancer and obesity in women younger than 40.

ASCO 2021

Combination Anlotinib and Sintilimab Exhibits Antitumor Activity in Advanced Endometrial Cancer

By

Sucharita Mistry, PhD

June 17, 2021

Nearly three-quarters of patients responded to treatment.

Gynecologic Cancer

Lynch Syndrome, Recurrence-Free Survival in Endometrial Cancer

By

Andrea S. Blevins Primeau, PhD, MBA

April 30, 2021

There was a trend of different 5-year RFS among the groups, with the shortest among patients with MLH1-hypermethylated disease at 78.6% compared with 95.5% among patients with other causes of MMRd.

The future of chemotherapy-based options for patients with HER2-negative MBC is evolving, with emerg

Gynecologic Cancer

Adjuvant Therapy Benefit Questioned in POLE-Mutated Endometrial Cancer

By

Leah Lawrence

April 27, 2021

The study researchers reported that endometrial cancers with these somatic mutations have unfavorable pathologic features.

Oral bisphosphonates may greatly reduce the risk of endometrial cancer.

Gynecologic Cancer

Peritoneal Cytology Prognostic in Stage II-III Endometrial Cancer

By

Leah Lawrence

April 23, 2021

Researchers found that the benefit of adjuvant therapy differed depending on the status of peritoneal cytology in women with endometrial cancer.

Gynecologic Cancer

Intrauterine Levonorgestrel Showed Activity in Endometrial Adenocarcinoma

By

Andrea S. Blevins Primeau, PhD, MBA

April 22, 2021

Researchers sought to determine if LNG-IUD is effective and whether the addition of weight loss or metformin can further improve response in patients with EAC and EHA.

Investigators of the observational study sought to clarify the time-dependent effects between long-term oral contraceptive use and risk for breast, ovarian, and endometrial cancer risk.

Gynecologic Cancer

Oral Contraceptives Found to Protect Against Ovarian and Endometrial Cancer for up to 35 Years After Discontinuation

By

Julia Faith Sklar

January 19, 2021

Investigators of the observational study sought to clarify the time-dependent effects between long-term oral contraceptive use and risk for breast, ovarian, and endometrial cancer risk.